What are the causes of dilated cardiomyopathy?

Causes of Dilated Cardiomyopathy

Genetic Causes (30-50% of Cases)

Genetic mutations are the single most important cause category, accounting for 30-50% of all dilated cardiomyopathy cases, with even higher rates in younger patients. 1

Key Genetic Patterns

• Autosomal-dominant inheritance is the predominant pattern, typically presenting in the third decade of life with progressive disease 1
• Cytoskeletal-sarcomere protein genes are most frequently implicated, disrupting the mechanical link between contractile apparatus and cellular structure 1
• LMNA (nuclear lamina) mutations carry particularly aggressive prognosis with high arrhythmia risk and early need for device therapy 1
• Dystrophin gene mutations cause X-linked dilated cardiomyopathy presenting in male adolescents/young adults with elevated creatine kinase levels 1
• Female dystrophin carriers develop milder disease in the fifth decade 1

Clinical Implication of Genetic Testing

• Echocardiographic screening of first-degree relatives identifies dilated cardiomyopathy in approximately 30% of families, even when the proband appears to have sporadic disease 1
• Comprehensive genetic panels detect causative mutations in 30-40% of patients tested 1
• Reduced penetrance is common—individuals may carry pathogenic variants yet never develop clinical disease 1

---

Toxic and Substance-Related Causes

Alcohol

• Alcohol-induced cardiomyopathy is particularly common in men aged 30-55 years with heavy drinking history and probable genetic susceptibility 1
• Patients frequently underreport consumption; careful questioning about current and past alcohol use is essential 1

Illicit Drugs

• Cocaine and methamphetamine can directly cause dilated cardiomyopathy 1

Chemotherapy

• Anthracycline chemotherapy agents are well-established cardiotoxins that induce dilated cardiomyopathy 1

---

Arrhythmia-Induced Cardiomyopathy (6.8% of Referral Cohorts)

Tachycardia-induced cardiomyopathy is a reversible cause that must not be missed.

• PVC burden ≥24% is independently associated with cardiomyopathy development, though the pathogenic threshold may be as low as 10% 1, 2
• Right ventricular outflow tract is the most common PVC origin (approximately 52% of cases) 1
• Radiofrequency ablation normalizes ejection fraction in 82% of patients within 6 months 1, 2
• Sustained ventricular rate ≥130 bpm during atrial fibrillation can itself induce dilated cardiomyopathy 1
• Aggressive rate control or rhythm restoration can markedly improve systolic function, with median ejection fraction rising from 25% to 52% 1

---

Infectious and Inflammatory Causes

Viral Myocarditis

• Parvovirus B19 and human herpesvirus 6 are the most frequent viral agents in Western Europe 1
• Coxsackie B and other enteroviruses remain important causes of acute and fulminant myocarditis progressing to dilated cardiomyopathy 1
• Viral myocarditis accounts for up to 75% of myocardial infarction with non-obstructive coronary arteries presentations 1
• Recent viral syndrome preceding heart failure symptoms suggests myocarditis, though serum antibody titers have low yield 1
• Viral persistence within myocardium is associated with reduction of ejection fraction after 6 months 3

HIV

• HIV-associated cardiomyopathy occurs in approximately 8% of asymptomatic HIV-positive individuals 1
• Screen for HIV in younger patients with unexplained dilated cardiomyopathy, particularly those with risk factors 1

Chagas Disease

• Trypanosoma cruzi infection causes progressive myocardial damage through parasite persistence and autoimmune responses 2
• Cardiac parasympathetic neurons are irreversibly damaged during acute infection, leaving unopposed sympathetic activation 2
• Prognosis is poor with 50% mortality within 4 years of heart failure onset 2

---

Autoimmune and Rheumatologic Causes

• Systemic lupus erythematosus patients are 1-3 times more likely to be hospitalized with newly diagnosed heart failure, with highest risk in women <45 years 2
• Three main mechanisms in SLE: atherosclerosis (2-10 fold increased MI risk), myocarditis/inflammation, and drug-induced impairments 2
• Rheumatoid arthritis and other connective tissue disorders can cause dilated cardiomyopathy 1
• Sarcoidosis may involve the heart even without clinical evidence of extracardiac disease 1

---

Metabolic and Endocrine Causes

• Both hyperthyroidism and hypothyroidism can cause or contribute to heart failure; measure thyroid-stimulating hormone in all patients 1, 2
• Hemochromatosis: Measure fasting transferrin saturation to screen, as mutated alleles are common in Northern European descent 1, 2
• Diabetes mellitus is a recognized secondary systemic cause 1

---

Infiltrative Diseases

• Amyloidosis can present with a dilated ventricular phenotype despite its typical restrictive physiology 1

---

Peripartum Cardiomyopathy

• Presents during the last month of pregnancy or within 5 months postpartum 2
• Risk factors include multiparity, advanced maternal age, obesity, and hypertension 2

---

Stress-Induced (Takotsubo) Cardiomyopathy

• Presents with acute, usually reversible left ventricular dysfunction triggered by emotional or physical stress, mediated by catecholamine excess 2
• Incidental coronary artery disease can be found in 10% of patients, complicating diagnosis 2

---

Neuromuscular Disorders

• Myotonic dystrophy type 1 (DM1) causes dilated cardiomyopathy in approximately 80% of patients, with cardiac manifestations being a leading cause of death 2
• Results from CTG trinucleotide repeat expansion in the DMPK gene; longer repeats correlate with earlier onset and more severe disease 2
• Cardiac involvement is particularly high-risk in younger patients aged 2-30 years, manifesting primarily as progressive conduction defects and tachyarrhythmias 2
• Myotonic dystrophy type 2 (DM2) shows less frequent cardiac involvement (10-20%) and dilated cardiomyopathy is uncommon 2

---

Disease Evolution and Phenotypic Overlap

• Patients with arrhythmogenic right ventricular cardiomyopathy, hypertrophic cardiomyopathy, or left ventricular non-compaction can later develop a dilated ventricular phenotype through remodeling 1
• Certain cardiomyopathies do not remain static and may evolve from one phenotypic category to another 1

---

Critical Diagnostic Pitfalls to Avoid

• Routine endomyocardial biopsy is not recommended for initial work-up because histology typically shows nonspecific findings that do not guide management 1
• Biopsy may be reserved for cases where a specific, treatable condition is strongly suspected (e.g., infiltrative disease, sarcoidosis) 1
• Non-ischemic cardiomyopathy can produce perfusion deficits and regional wall-motion abnormalities that mimic ischemic heart disease on non-invasive testing 1
• Approximately half of patients with heart failure and reduced ejection fraction have normal or near-normal coronary arteries on angiography 1
• Cardiac MRI should be considered at least once in every dilated cardiomyopathy patient for tissue characterization (fibrosis, edema, infiltration) to suggest underlying cause 1, 2
• A 3-generation family history is essential when assessing cardiomyopathy causes, as genetic mutations account for 30-50% of cases 2